TNG Pharmaceuticals

About:

TNG Pharmaceuticals, a Louisville, KY based company is focused on the research and development of our patented vaccine, FlyVax.

Website: http://flyvax.com

Top Investors: Texas HALO Fund, Bluegrass Angels, Commonwealth Seed Capital, Yearling Fund II, Investment Management Group

Description:

TNG Pharmaceuticals, a Louisville, KY based company is focused on the research and development of our patented vaccine, FlyVax. TNG Pharmaceuticals began at the University of Louisville in the Entrepreneurship MBA program. TNG competed on a global business plan competition circuit: winning four of five competitions, including the world's largest, richest, and most prestigious competitions.

Total Funding Amount:

$4.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Louisville, Kentucky, United States

Founded Date:

2011-01-01

Contact Email:

website(AT)flyvax.com

Founders:

Jenny Corbin, Larry Horn

Number of Employees:

1-10

Last Funding Date:

2014-02-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai